Persones / Equip Humà

Marçal Pastor-Anglada

Buscador de publicacions

Publicacions

  • Pena-Rodriguez, E, García-Vega L, Lajarin Reinares M, Pastor-Anglada M, Perez-Torras S and Fernandez-Campos, F.

    Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation

    MOLECULAR PHARMACEUTICS . 20(5): 2317-2325.

    [doi:10.1021/acs.molpharmaceut.2c00796]

  • Brunet M and Pastor-Anglada M.

    Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics.

    Pharmaceutics . 14(9): 1755. Nº de cites: 3

    [doi:10.3390/pharmaceutics14091755]

  • Pastor-Anglada M, Mata A and Perez-Torras S.

    Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29)

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(15): 8770. Nº de cites: 3

    [doi:10.3390/ijms23158770]

  • Boces-Pascual, C, Mata A, Martin-Satue, M, Boix, L, Gironella, M, Pastor-Anglada M and Perez-Torras S.

    OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1

    CELLULAR AND MOLECULAR LIFE SCIENCES . 78(23): 7505-7518. Nº de cites: 2

    [doi:10.1007/s00018-021-03959-8]

  • Guillén-Gómez E, Silva I, Serra N, Caballero F, Leal J, Breda A, San Martín R, Pastor-Anglada M, Ballarín JA, Guirado L and Díaz-Encarnación MM.

    From Inflammation to the Onset of Fibrosis through A(2A) Receptors in Kidneys from Deceased Donors.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 21(22): . Nº de cites: 4

    [doi:10.3390/ijms21228826]

  • Jaramillo AC, Hubeek I, Broekhuizen R, Pastor-Anglada M, Kaspers GJL, Jansen G, Cloos J and Peters GJ.

    Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 39(10-12): 1379-1388. Nº de cites: 6

    [doi:10.1080/15257770.2020.1746803]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Nº de cites: 5

    [doi:10.1016/j.phrs.2019.104556]

  • Vaskó B, Juhász V, Tóth B, Kurunczi A, Fekete Z, Zolnerciks JK, Kis E, Magnan R, Bidon-Chanal Badia A, Pastor-Anglada M, Hazai E, Bikadi Z, Fülöp F and Krajcsi P.

    Inhibitor selectivity of CNTs and ENTs.

    Xenobiotica . 49(7): 840-851. Nº de cites: 3

    [doi:10.1080/00498254.2018.1501832]

  • Perez-Torras S, Mata-Ventosa A, Drögemöller B, Tarailo-Graovac M, Meijer J, Meinsma R, van Cruchten AG, Kulik W, Viel-Oliva A, Bidon-Chanal A, Ross CJ, Wassermann WW, van Karnebeek CDM, Pastor-Anglada M and van Kuilenburg ABP.

    Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE . 1865(6): 1182-1191. Nº de cites: 7

    [doi:10.1016/j.bbadis.2019.01.013]

  • Grañe-Boladeras N, Williams D, Tarmakova Z, Stevanovic K, Villani LA, Mehrabi P, Siu KWM, Pastor-Anglada M and Coe IR.

    Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.

    FASEB JOURNAL . 33(3): 3841-3850. Nº de cites: 8

    [doi:10.1096/fj.201800440RR]